These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 800972)

  • 1. The diuretic effect of muzolimine (Bay g 2821) on hepatogenic ascites.
    Heinrich F; Loew D; Dýcka J
    Curr Med Res Opin; 1976-1977; 4(10):706-15. PubMed ID: 800972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new loop diuretic (muzolimine) in cirrhosis with ascites: comparison with furosemide.
    Bernardi M; De Palma R; Trevisani F; Santini C; Patrono D; Motta R; Servadei D; Gasbarrini G
    Hepatology; 1986; 6(3):400-5. PubMed ID: 3519416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study.
    Fiaccadori F; Pedretti G; Pasetti G; Pizzaferri P; Elia G
    Clin Investig; 1993 Jul; 71(7):579-84. PubMed ID: 8374255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
    Fuller RK; Khambatta PB; Gobezie GC
    JAMA; 1977 Mar; 237(10):972-5. PubMed ID: 319263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
    Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
    Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
    Knauf H; Mutschler E
    Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
    Fogel MR; Sawhney VK; Neal EA; Miller RG; Knauer CM; Gregory PB
    J Clin Gastroenterol; 1981; 3 Suppl 1():73-80. PubMed ID: 7035545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the pharmacodynamic effects of furosemide and BAY g 2821 and correlation of the pharmacodynamics and pharmacokinetics of BAY g 2821 (muzolimine).
    Loew D; Ritter W; Dycka J
    Eur J Clin Pharmacol; 1977 Dec; 12(5):341-4. PubMed ID: 598405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V; Porcellati C; Corea L; Todisco T
    Minerva Nefrol; 1968; 15(4):258-60. PubMed ID: 5745815
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacodynamic and pharmacokinetic studies of muzolimine in patients with hepatogeneous ascites (author's transl)].
    Loew D; Dýcka J; Pfleiderer T; Ritter W
    Z Gastroenterol; 1980 Oct; 18(10):537-42. PubMed ID: 7456563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
    Pérez-Ayuso RM; Arroyo V; Planas R; Gaya J; Bory F; Rimola A; Rivera F; Rodés J
    Gastroenterology; 1983 May; 84(5 Pt 1):961-8. PubMed ID: 6339312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V; Bosch J; Casamitjana R; Cabrera J; Rivera F; Rodés J
    Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors influencing the therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Ljubicić N; Kujundzić M; Banić M; Vrkljan M
    Scand J Gastroenterol; 1998 Apr; 33(4):441-7. PubMed ID: 9605268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bumetanide, spironolactone and a combination of the two, in the treatment of ascites due to liver disease. A prospective, controlled, randomized trial.
    Sarin SK; Sachdev G; Mishra SP; Sundaram KR; Shrivastwa A; Talukdar V; Broor SL
    Digestion; 1988; 41(2):101-7. PubMed ID: 3065101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muzolimine in chronic renal failure: a study in 16 patients.
    Stratta P; Dogliani M; Squiccimarro G; Colla L; Vercellone A
    Z Kardiol; 1985; 74 Suppl 2():125-8. PubMed ID: 4002786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
    Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.
    Fernández-Esparrach G; Guevara M; Sort P; Pardo A; Jiménez W; Ginès P; Planas R; Lebrec D; Geuvel A; Elewaut A; Adler M; Arroyo V
    J Hepatol; 1997 Mar; 26(3):614-20. PubMed ID: 9075669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.
    Santos J; Planas R; Pardo A; Durández R; Cabré E; Morillas RM; Granada ML; Jiménez JA; Quintero E; Gassull MA
    J Hepatol; 2003 Aug; 39(2):187-92. PubMed ID: 12873814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.